Phase II study of oral ftorafur and uracil in patients with advanced renal cell carcinoma.
Esteban
E
E
Buesa
J M
JM
Cueva
J
J
Fernández
Y
Y
Peláez
I
I
Fernández
J L
JL
Sanz
A
A
Palacio
I
I
Estrada
E
E
Gracia
J M
JM
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D005641:Tegafur; D014498:Uracil